These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3399887)

  • 1. Another glitch for AIDS vaccines?
    Barnes DM
    Science; 1988 Jul; 241(4865):533-4. PubMed ID: 3399887
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of HIV vaccine.
    Robson B; Fishleigh RV; Morrison CA
    Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
    Schild GC; Minor PD
    Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
    [No Abstract]   [Full Text] [Related]  

  • 4. Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?
    Robinson WE; Montefiori DC; Mitchell WM
    Lancet; 1988 Apr; 1(8589):830-1. PubMed ID: 2895350
    [No Abstract]   [Full Text] [Related]  

  • 5. The AIDS virus can take on many guises.
    Marx JL
    Science; 1988 Aug; 241(4869):1039-40. PubMed ID: 2457946
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
    Lasky LA; Groopman JE; Fennie CW; Benz PM; Capon DJ; Dowbenko DJ; Nakamura GR; Nunes WM; Renz ME; Berman PW
    Science; 1986 Jul; 233(4760):209-12. PubMed ID: 3014647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstacles to an AIDS vaccine.
    Barnes DM
    Science; 1988 May; 240(4853):719-21. PubMed ID: 2834823
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development.
    Martínez-A C; Marcos MA; de la Hera A; Marquez C; Alonso JM; Toribio ML; Coutinho A
    Lancet; 1988 Feb; 1(8583):454-7. PubMed ID: 2449591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HTLV III/LAV envelope protein.
    Bicker U
    Nature; 1986 Nov 27-Dec 3; 324(6095):307. PubMed ID: 3466037
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV infection and the immune system.
    Sattentau QJ
    Biochim Biophys Acta; 1989 Dec; 989(3):255-68. PubMed ID: 2695169
    [No Abstract]   [Full Text] [Related]  

  • 11. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS vaccine.
    Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
    [No Abstract]   [Full Text] [Related]  

  • 14. Human trials of AIDS vaccines: current status and future directions.
    Koff WC; Fauci AS
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccine.
    Minn Med; 1991 Jan; 74(1):41. PubMed ID: 2002792
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for prevention of and early intervention against HIV.
    Bolognesi DP
    JAMA; 1989 May; 261(20):3007-13. PubMed ID: 2654429
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.
    Goudsmit J; Lange JM; Paul DA; Dawson GJ
    J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV: virology and vaccination].
    Löwer J; Norley SG; Kraus G; Werner A; Kurth R
    Verh Dtsch Ges Inn Med; 1988; 94():537-42. PubMed ID: 3061230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

  • 20. Subunit vaccines against exogenous retroviruses: overview and perspectives.
    Hunsmann G
    Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.